Portola is a biotechnology company that develops and commercializes novel therapeutics for the treatment of thrombotic and hematologic disorders... Read more
Portola is a biotechnology company that develops and commercializes novel therapeutics for the treatment of thrombotic and hematologic disorders... Read more
CEO
Add
News
Nov 21, 2022
PR Newswire
Press Release: Portola Pharmaceuticals Inc : Berman Tabacco Announces Class Action Settlement In Securities Litigation Involving Purchasers of Portola Pharmaceuticals, Inc. Common Stock
Jul 08, 2020
Endpoints News
Portola: 'Fundamentally different' from Portola, Dutch biotech lands 32M to steer anti-anticoagulant through the clinic
Jul 02, 2020
BioSpace
Portola: Alexion Completes Acquisition of Portola
Jun 30, 2020
MarketScreener
Portola: Portola Pharmaceuticals : Amendment to a previously filed SC TO-T
Jun 18, 2020
MarketScreener
Portola: Rigrodsky & Long, P.A. Files Class Action Suit Against Portola Pharmaceuticals, Inc.
May 18, 2020
PR Newswire
Press Release: Portola : Portola Pharmaceuticals Announces Virtual 2020 Annual Stockholder Meeting
May 17, 2020
Seeking Alpha
Portola: Portola Pharmaceuticals - This Name You Haven't Heard Of Is The Next Big COVID-19 Company
May 07, 2020
BioPharma-Reporter
Portola: Alexion in $1.4bn buyout for reversal agent
May 07, 2020
Seeking Alpha
Portola: Biotech M&A Deal Looks Too Rich For Its Blood
May 05, 2020
The Business Journals: San Francisco Business Times
Portola: East Coast biotech makes $1.4 billion play for Peninsula company
Portola Pharmaceuticals Inc Competitors
1
2
3
4
5
6
7
8
9
10